Natra, S.A. announced consolidated earnings results for the first half year ended June 30, 2013. For the first half, the company reported net business turnover of EUR 170,735,000 against EUR 168,956,000 a year ago. Profit from operations was EUR 7,163,000 against EUR 5,377,000 a year ago.

Profit before taxes was EUR 1,358,000 against loss before taxes of EUR 8,523,000 a year ago. Results from continued operations were EUR 47,000 against negative results from continued operations of EUR 9,695,000 a year ago. Net result was EUR 14,000 against negative net result of EUR 9,732,000 a year ago.

Net loss attributable to shareholders of the main company was EUR 1,162,000 against EUR 5,376,000 a year ago. EBITDA was EUR 12,810,000 for the period ended June 30, 2013. In the first six months of the year the company reduced its consolidated net debt by 8.2% to 148.37 million.

The positive evolution of this result was mainly due to the group's operational improvement, the reduction of financial costs following the cancelation of Natraceutical's syndicated loan and also the exiting of the stake in Naturex from the scope of consolidation, which in the first half of 2012 raised a loss of EUR 7.29 million for its value change in the stock market. On June 30, 2013, the company's consolidated net financial debt amounted to EUR 148.37 million, of which EUR 0.99 million corresponded to Natraceutical.